Insider Trading History of Debel Marlene

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Debel Marlene since 2020. This trader's CIK number is 1770295. At the time of last reporting, Debel Marlene was the EVP & Chief Risk Officer of Metlife Inc. (stock ticker symbol MET). Also see all insider trading activities at Metlife Inc.

Note that in the past DEBEL MARLENE also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Metlife Inc (MET) by Debel Marlene

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 MET 0 $0 22,810 $1,890,584 22,810 $915,137
2023 MET 0 $0 9,391 $593,323 10,911 $492,631
2021 MET 0 $0 11,000 $710,424 0 $0
2020 MET 0 $0 0 $0 3,704 $0

Yearly summary of insider trading at Raymond James Financial Inc (RJF) by Debel Marlene

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 RJF 0 $0 0 $0 1,643 $0
2023 RJF 0 $0 0 $0 1,683 $0
2022 RJF 0 $0 0 $0 1,925 $0
2021 RJF 0 $0 0 $0 605 $0


Insider trading activities at 2 companies by Debel Marlene:

1. Metlife Inc (MET)

2. Raymond James Financial Inc (RJF)

Table 1. Insider trading of Metlife Inc (MET) by Debel Marlene

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-12-13 MET Option Ex 22,810 40.12 915,137
2024-12-13 MET Sale 22,810 82.88 1,890,584
2023-08-09 MET Option Ex 10,911 45.15 492,631
2023-08-09 MET Sale 9,391 63.18 593,323
2021-05-11 MET Sale 11,000 64.58 710,424
2020-03-02 MET Option Ex 3,704 .00 0

Table 2. Insider trading of Raymond James Financial Inc (RJF) by Debel Marlene

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-22 RJF Option Ex 1,643 .00 0
2023-02-23 RJF Option Ex 1,683 .00 0
2022-02-24 RJF Option Ex 1,925 .00 0
2021-12-02 RJF Option Ex 605 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Debel Marlene (EVP & Chief Risk Officer of Metlife Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.